Weekly round-up #131
Weekly Round-up #131
Welcome to the VALIDATE Weekly Round-up Number 131! This week we have launched our latest round of training grants and, as usual, we're updating you on jobs opportunities, upcoming events and recent publications.
Training Grant Round 10 is now open!
VALIDATE Associates can apply for grants of up to £3000 to help you take advantage of training opportunities that will contribute to your professional development in our research field. We are particularly keen to receive applications from researchers based in low and middle-income countries (LMICs), so please do share details of our grants with colleagues in these countries. You can apply via the Training Grants Page. The deadline is 13 October 2020!
- Hic-Vac Public Engagement Awards - funding innovative and creative projects that improve the public’s awareness and understanding of controlled human infection studies, build trust in them, and probe risk perceptions – deadline 21 August 2020
- AMS Starter Grants for Clinical Lecturers - This scheme is targeted at those who are in the earlier years of their Clinical Lecturer appointment - deadline 8 September 2020
- MRC Career Development Award - Supporting talented post-doctoral researchers and provides funding for challenging research programmes – deadline 16 September 2020
You will find more exciting funding opportunities on our funding page.
Training Opportunities and Events:
-
Biochemistry Focus Webinar: How to deliver biomolecular science honours research projects with limited lab bench time, Online Course, 24 August 2020
You will find more interesting opportunities on our Training and Events pages.
Job Opportunities:
-
Clinical Trial Manager, UCL, London UK, deadline 26 August 2020
-
Research Specialist, Host-Pathogen Biology, Rockefeller University, New York USA, no stated deadline
Our jobs page has all the latest vacancies.
-
Host urine immunological biomarkers as potential candidates for the diagnosis of tuberculosis, Eribo OA et al including VALIDATE Member Gerhard Walzl, in International Journal of Infectious Disease
-
BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines, Segura-Cerda CA et al including VALIDATE Member Mario Alberto Flores-Valdez, in NPJ Vaccines
-
Transcriptional portrait of M. bovis BCG during biofilm production shows genes differentially expressed during intercellular aggregation and substrate attachment, VALIDATE Member Mario Alberto Flores-Valdez et al, in NPJ Vaccines
-
Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice, Salari S et al, in Parasites & Vectors
-
Dual host-intracellular parasite transcriptome of enucleated cells hosting Leishmania amazonensis: control of half-life of host cell transcripts by the parasite, Orikaza C et al including VALIDATE members Hiro Goto and Eduardo Ramos Milton-Sanchez, in Infection and Immunity
Highlights on Twitter this week
The European Commission authorised a new treatment for people with highly drug-resistant forms of TB, Nature Careers published an article on the uncertain future as universities struggle with the effects of the pandemic, and TB News Daily shared an article on how to stop COVID-19 fuelling a resurgence of TB and other diseases. TB Alliance also shared details of a highly effective new drug regimen for treating TB, Write That PhD shared some advice on how to write a good research proposal, and The Vaccine Confidence Project celebrated being one of the winners of the Facebook awards. NowThis shared a video profiling the three women who overcame negative stereotypes in the early 1900s to develop the first Whooping Cough vaccine and the Stop TB Partnership published their Global Plan in Japanese for the first time.
Follow VALIDATE on Twitter.
Published: 19 August 2020
